Serina Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Highlights
August 09, 2024 16:15 ET
|
Serina Therapeutics, Inc.
HUNTSVILLE, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Serina Therapeutics (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform™ drug delivery...
INFINT Acquisition Corporation Announces Intention to Voluntarily Delist from NYSE American LLC, Conditional Upon Consummation of its Pending Business Combination with Seamless Group Inc.
August 09, 2024 16:15 ET
|
INFINT Acquisition Corporation
NEW YORK, NEW YORK, Aug. 09, 2024 (GLOBE NEWSWIRE) -- INFINT Acquisition Corporation (the “Company”) today announced that, in connection with its proposed business combination (the “Business...
Motorsport Games Reports Second Quarter 2024 Financial Results
August 09, 2024 16:10 ET
|
Motorsport Games Inc.
Motorsport Games Inc (NASDAQ:MSGM) reports its second quarter 2024 financial result
FutureFuel Releases Second Quarter 2024 Results
August 09, 2024 16:05 ET
|
FutureFuel Corp.
CLAYTON, Mo., Aug. 09, 2024 (GLOBE NEWSWIRE) -- FutureFuel Corp. (NYSE: FF) (“FutureFuel”), a manufacturer of custom and performance chemicals and biofuels, today announced financial results for the...
Avenue Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights
August 09, 2024 16:05 ET
|
Avenue Therapeutics
- Last patient visit complete in Phase 1b/2a clinical trial of AJ201 for spinal and bulbar muscular atrophy; topline data anticipated in second half of 2024 – - Raised $4.4 million in gross proceeds...
Globalink Investment Inc. Announces Extension of the Deadline to Complete a Business Combination to September 9, 2024
August 09, 2024 16:05 ET
|
Globalink Investment Inc.
New York, NY, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Globalink Investment Inc. (Nasdaq: GLLI, GLLIW, GLLIR, GLLIU) (“Globalink” or the “Company”), a special purpose acquisition company, announced today...
Humacyte Announces FDA Communication of Additional Time Required to Complete Review of acellular tissue engineered vessel (ATEV™) BLA for the Treatment of Vascular Trauma
August 09, 2024 16:05 ET
|
Humacyte, Inc
– 2nd quarter conference call to be held Tuesday, August 13th, at 8:30 a.m. ET – DURHAM, N.C., Aug. 09, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage...
Fly-E Group, Inc. Launches E-Bike Rental Service to Address Growing Market Demand and Participates in NYC’s Trade-In Program
August 09, 2024 16:05 ET
|
Fly-E Group, Inc.
NEW YORK, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Fly-E Group, Inc. (Nasdaq: FLYE) ("Fly-E" or the "Company"), an electric vehicle company engaged in designing, installing and selling smart electric...
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 09, 2024 16:05 ET
|
TELA Bio, Inc.
MALVERN, Pa., Aug. 09, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction...
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 09, 2024 16:05 ET
|
Vera Therapeutics
BRISBANE, Calif., Aug. 09, 2024 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that on August 6, 2024, the Compensation Committee granted inducement awards consisting of...
- August 09, 2024 16:10 ET Motorsport Games Reports Second Quarter 2024 Financial Results
- August 09, 2024 16:04 ET NurExone's ExoPTEN, loaded with siRNA, Demonstrates Ability to Target Injury and Inflammation Sites – New Study